BGCKX | OTCRX | BGCKX / OTCRX | |
Total Expense Ratio | 1.29 | 2.32 | 56% |
Annual Report Gross Expense Ratio | 1.31 | 2.49 | 53% |
Fund Existence | 10 years | 12 years | - |
Gain YTD | 11.259 | -23.452 | -48% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 2500 | 200,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.88B | 23.6M | 29,157% |
Annual Yield % from dividends | 9.94 | 0.58 | 1,706% |
Returns for 1 year | 13.65 | -26.45 | -52% |
Returns for 3 years | 60.24 | -11.30 | -533% |
Returns for 5 years | 60.80 | -5.74 | -1,059% |
Returns for 10 years | N/A | 0.75 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PXLIX | 14.34 | 0.06 | +0.42% |
Impax Large Cap Fund Institutional | |||
FIRAX | 10.33 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate A | |||
GIRMX | 29.64 | -0.05 | -0.17% |
Goldman Sachs Emerging Markets Eq Inv | |||
BIPIX | 56.46 | -0.10 | -0.18% |
ProFunds Biotechnology UltraSector Inv | |||
MINJX | 45.87 | -0.31 | -0.67% |
MFS International Intrinsic Value R6 |